VR Logo

Synthetic Biologics Inc. (SYN) download report


Healthcare | Biotechnology & Pharma Research

Synthetic Biologics Inc. (SYN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need.

IPO Date: 26-Jun-2006

CEO, CFO, Treasurer, Corp. Sec. & Director: Mr. Steven A. Shallcross CPA

Chief Operating Officer: Dr. Frank Tufaro Ph.D.

Listing: NYSE: SYN

Country: United States

Headquarters: Rockville, MD

Website: https://www.syntheticbiologics.com

Key Facts

Market cap: $22.51 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-16.00 Mln

Cash: $56.69 Mln

Total Debt: $1.77 Mln

Insider's Holding: 1.98%

Liquidity: Low

52 Week range: $1.33 - 16.45

Shares outstanding: 15,843,800

10 Years Aggregate:

  • CFO: $-175.92 Mln
  • EBITDA: $-212.89 Mln
  • Net Profit: $-188.32 Mln

Stock Performance

Time Period Synthetic Biologics (SYN) S&P BSE Sensex S&P Small-Cap 600
YTD-45.562.08-8.13
1 month-39.269.3214.13
3 months-31.639.9412.23
1 Year-70.609.05-5.78
3 Years-31.3816.5311.43
5 Years-62.0713.769.16
10 Years-46.2112.9711.05
As on 12-Aug-2022
Year Synthetic Biologics (SYN) S&P Small-Cap 600 S&P BSE Sensex
2021-29.5025.2721.99
2020-24.449.5715.75
2019-9.4820.8614.38
2018-96.79-9.705.87
2017-33.3911.7327.91
2016-66.7024.741.95
201556.85-3.36-5.03